GlassScriptPhysician profile
Joshua J Feiner
NPI 1750560421
$5,257.17
in general payments reported to CMS, 2019-2025
43 companies · $1,696 in 2025
The $1,696 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $238 · 2021: $526 · 2022: $1,268 · 2023: $327 · 2024: $729 · 2025: $1,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,696 · Education: $57.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,695.86 |
| Education | $57.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $595.95 | 2019-2025 | Tepezza, Evenity, Prolia |
| Abbott Laboratories | $465.68 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2, Mitraclip |
| Novo Nordisk INC | $373.12 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $331.68 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Xeris Pharmaceuticals, INC. | $320.19 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Medtronic, INC. | $265.65 | 2021-2025 | Minimed 780g |
| Beta Bionics, INC. | $246.03 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Boehringer Ingelheim Pharmaceuticals, INC. | $211.05 | 2019-2025 | Jardiance, Synjardy |
| Genzyme Corporation | $200.00 | 2019 | |
| Amneal Pharmaceuticals LLC | $188.36 | 2022-2025 | Unithroid |
| Sanofi-Aventis U.S. LLC | $180.93 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $172.52 | 2019-2024 | Verquvo, Gardasil, Capvaxive |
| Dexcom, INC. | $138.81 | 2022-2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $132.41 | 2019-2022 | |
| Recordati_rare_diseases_inc. | $123.46 | 2025 | Isturisa |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Feiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.